As of 2025-05-21, the EV/EBITDA ratio of China Biologic Products Holdings Inc (CBPO) is
15.90.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CBPO's latest enterprise value
is 3,978.85 mil USD. CBPO's TTM EBITDA according to its financial statements is
250.20 mil USD. Dividing these 2
quantities gives us the above CBPO EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
15.6x - 20.4x |
17.8x |
| Forward P/E multiples |
13.2x - 14.3x |
13.8x |
| Fair Price |
105.07 - 149.26 |
120.51 |
| Upside |
-12.4% - 24.4% |
0.4% |